Flexible Composite Next Generation Tissue Separating Mesh in Laparoscopic Incisional/Ventral Hernia Repair

Overview

This is a multi-center, observational study of incisional/ventral hernia repair with NG-TSM laparoscopically. The study is not randomized and has a single treatment design assessing NG-TSM intra-operatively, its ease of use and handling characteristics.

Full Title of Study: “Single-Arm, Prospective, Multi-Center Observational Study of a Flexible Composite Next Generation Tissue Separating Mesh(NG-TSM)to Assess Ease of Use and Early Outcomes in Laparoscopic Incisional/Ventral Hernia”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: December 2010

Detailed Description

The objectives of the study are to evaluate the ease of use of NG-TSM intra-operatively in laparoscopic incisional/ventral hernia repair, and assessing early outcomes post-operatively following mesh implantation, including seroma formation, hematoma, wound complications, infections, early recurrences, adverse events, and subject comfort, as well as health economic data to include quality of life, subject satisfaction data, time of procedure, length of stay, re-hospitalization, and extended hospitalization.

Interventions

  • Device: NG-TSM
    • Flexible Composite Next Generation Tissue Separating Mesh

Arms, Groups and Cohorts

  • NG-TSM
    • Patients receiving NG-TSM to repair an abdominal incisional/ventral hernia

Participating in This Clinical Trial

Inclusion Criteria

  • Subject must be able to provide written informed consent – Male or female subjects that are ≥ 18 years of age – Female subjects must be using adequate contraception, or be surgically sterile, postmenopausal or practicing abstinence, and not planning to become pregnant – Planned laparoscopic procedure to repair an abdominal incisional/ventral hernia that requires the addition of reinforcing or bridging material to obtain the desired surgical result Exclusion Criteria:

  • Subjects with a potential growth as NGTSM will not stretch significantly – Female subjects who are pregnant on the day of implantation – Surgical site (mesh implantation site) that is classified as contaminated (acute, non purulent, inflamed) or dirty/infected (containing retained devitalized tissue and those that involve existing clinical infection or perforated viscera) – Subjects who have received investigational articles less than 30 days prior to enrollment or who are currently receiving investigational products or devices – Employees of the investigator or study center with direct involvement in the proposed study or other studies under the direction of that investigator or study center

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Ethicon, Inc.
  • Provider of Information About this Clinical Study
    • Lynn McRoy MD / Medical Director, Ethicon
  • Overall Official(s)
    • Lynn McRoy, MD, Study Director, Ethicon, Inc.

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.